The legacy status of Viagra, and the parent company copyright, presents a complex question for shareholders . While earnings initially surged, the impending patent expiry and rising generic presence https://montyhcdm785893.designertoblog.com/72963611/the-blue-pill-and-pharma-a-speculative-investment